Key result
Angiojet rheolytic thrombectomy was described as a novel technique for treating acute massive thrombosis of the native aortic valve and left ventricular assist device in 1 heart failure patient.
Case Report (n=1)
Angiojet rheolytic thrombectomy may be a feasible novel application for treating acute massive thrombosis of the native aortic valve and LVAD in heart failure patients.
Answers are grounded in this paper and cite their sources.
Should not change practice for LVAD thrombosis; leaves open feasibility of rheolytic thrombectomy pending controlled studies.
With the diffusion of implantable ventricular assist pumps in heart failure patients refractory to treatments or ineligible to transplantation, acute aortic valve and device thrombosis is an unusual but potentially increasing complication. We report a novel application of Angiojet rheolytic thrombectomy for acute and massive thrombosis of the native aortic valve and of the left ventricular assist device in a heart failure patient. The technical execution and clinical experience with this technique is described.
No takes yet. Share an insight, caveat, or question.
Barbieri et al. (2011) conducted a case report in End-stage heart failure with acute aortic valve and device thrombosis (n=1). Angiojet rheolytic thrombectomy was evaluated. Angiojet rheolytic thrombectomy was described as a novel technique for treating acute massive thrombosis of the native aortic valve and left ventricular assist device in 1 heart failure patient.
Synapse has enriched 10 related papers. Consider them for comparative context: